Healthcare

Public-Private collaboration fuels the U.S. biopharmaceutical ecosystem

Healthcare

Cancer death rate continues decline due to advances in treatment

For the second year in a row, The American Cancer Society (ACS) reports a record ...

By Value Spots

10 mins ago

Healthcare

Johnson & Johnson’s COVID-19 vaccine production lags goals as data readout nears: NYT

Amid slower than expected rollouts for the Pfizer and Moderna COVID-19 vaccines in the U.S., ...

By Value Spots

9 hours ago

Healthcare

JPM, Day 3: Fujifilm’s bio CDMO growth, Catalent’s ‘coveted’ COVID-19 assets, Teva’s post-cutback aims—and more

Typically, Day 3 of the J.P. Morgan Healthcare Conference is when some folks start packing ...

By Value Spots

17 hours ago

Healthcare

What do Novartis deal, PD-1 competition in China mean for tislelizumab? Here’s what BeiGene’s CEO has to say

BeiGene has had a few busy weeks. In its home base of China, the company ...

By Value Spots

1 day ago

Healthcare

JPM: Jazz eyes a ‘dramatic’ shift to new-drug revenue by 2022, CEO says

Jazz Pharmaceuticals is in the middle of a four-product launch cycle—one in 2019, two in ...

By Value Spots

1 day ago

Healthcare

Moderna hitches a ride with Uber to boost vaccine confidence—and, of course, drive access

COVID-19 vaccine maker Moderna is looking for a lift from Uber—a collaboration lift, that is. The two ...

By Value Spots

2 days ago

Catalent inks deal to offload blow-fill-seal business to SK Capital

Healthcare

CDMO Catalent tackles Warp Speed juggling act with new $50M Bloomington line, Acorda plant buyout

Catalent hustled to expand its manufacturing capacity last year as it juggled a surge of COVID-19 work with ...

By Value Spots

2 days ago

Healthcare

He’s in! ‘Shark Tank’ star Cuban launches generics maker promising ‘radically’ low-cost drugs

Billionaire investor Mark Cuban is famous for critiquing startup plans on the hit TV series ...

By Value Spots

2 days ago

Fierce Pharma Asia—China's PD-1 coverage; Fujifilm's $2B U.S. expansion; Sinopharm COVID-19 vaccine data

Healthcare

Fierce Pharma Asia—BeiGene-Novartis PD-1 deal; Sinovac vaccine; Celltrion antibody COVID-19 data

Novartis plunked down up to $2.2 billion for BeiGene’s China-approved PD-1 drug tislelizumab to complement ...

By Value Spots

3 days ago

Healthcare

Fujifilm continues CMDO expansion spree with $76M in funding for new Boston site

That didn’t take long. Fujifilm is laying plans for a new manufacturing facility in Watertown, ...

By Value Spots

3 days ago

Healthcare

Cancer death rate continues decline due to advances in treatment

Johnson & Johnson’s COVID-19 vaccine production lags goals as data readout nears: NYT

JPM, Day 3: Fujifilm’s bio CDMO growth, Catalent’s ‘coveted’ COVID-19 assets, Teva’s post-cutback aims—and more

What do Novartis deal, PD-1 competition in China mean for tislelizumab? Here’s what BeiGene’s CEO has to say

JPM: Jazz eyes a ‘dramatic’ shift to new-drug revenue by 2022, CEO says

Moderna hitches a ride with Uber to boost vaccine confidence—and, of course, drive access

CDMO Catalent tackles Warp Speed juggling act with new $50M Bloomington line, Acorda plant buyout

He’s in! ‘Shark Tank’ star Cuban launches generics maker promising ‘radically’ low-cost drugs

Fierce Pharma Asia—BeiGene-Novartis PD-1 deal; Sinovac vaccine; Celltrion antibody COVID-19 data

Fujifilm continues CMDO expansion spree with $76M in funding for new Boston site

Posts List

‘My brother was my best friend’: He moved into my late father’s home, changed the locks and blew through his money. Should I pursue criminal charges?

Scenes From a Pandemic Holiday Road Trip

Salesforce, Slack, Box and more

Categories

Healthcare

Posts List

Categories

Latest Posts